Close Menu

NEW YORK (GenomeWeb) – Fulgent Genetics reported after the close of the market on Wednesday a 27 percent drop in revenues year over year for the fourth quarter.

For the three months ended Dec. 31, 2017, the Temple City, California-based genetic testing firm posted $4.3 million in revenues, down from $5.9 million in Q4 2016.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Aug
12
Sponsored by
Truvian

Antibody testing is expected to play an important role in the management of the COVID-19 pandemic. 

Aug
18

As worldwide COVID-19 cases continue to rise, there is a significant need to increase testing and population surveillance capacity.

Oct
09
Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.